Spectranetics Corp. (SPNC)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

9965 FEDERAL DRIVE COLORADO SPRINGS, CO 80921

Spectranetics Corp. develops, makes and markets a proprietary excimer laser, the CVX-300, for the treatment of certain coronary and vascular conditions. The company's system includes the laser unit and various fiber optic delivery devices, including disposable catheters and sheaths.

View SEC Filings from SPNC instead.

View recent insider trading info

Funds Holding SPNC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SPNC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PELAK DANIEL A

  • Director
No longer subject to file 2017-08-09 0

SCHERMERHORN TODD C

  • Director
No longer subject to file 2017-08-09 0

FLETCHER R JOHN

  • Director
No longer subject to file 2017-08-09 0

JOHNSON B KRISTINE

  • Director
No longer subject to file 2017-08-09 0

RUGGIO JOSEPH M

  • Director
No longer subject to file 2017-08-09 0

JENNINGS WILLIAM C

  • Director
No longer subject to file 2017-08-09 0

MATIN SHAHRIAR CHIEF OPERATING OFFICER

  • Officer
No longer subject to file 2017-08-09 0

SAINZ MARIA

  • Director
No longer subject to file 2017-08-09 0

DRAKE SCOTT WILLIAM PRESIDENT, CEO

  • Officer
  • Director
No longer subject to file 2017-08-09 0

FORD-SERBU DONNA SR. VP SALES AND MKTG, LM

  • Officer
No longer subject to file 2017-08-09 0

MCMAHAN STACY POWELL CFO

  • Officer
No longer subject to file 2017-08-09 0

HUTTON SCOTT GENERAL MANAGER, VI

  • Officer
No longer subject to file 2017-08-09 0

SCHEINER UDO EDWIN SR. VP, INT'L OPERATIONS

  • Officer
0 2016-03-31 0

CHILDS GUY A

  • FORMER CFO
No longer subject to file 2015-12-31 0

BRIDGES KIMBERLY MCINTOSH SR VP, SALES & MKTG, VI

  • Officer
4,431 2015-07-29 0

BOWE WADE A VICE PRESIDENT R&D

  • Officer
0 2015-06-11 0

FUCHS ROBERT MICHAEL SR. VP, GLOBAL HUMAN RESOURCES

  • Officer
0 2015-06-11 0

BYRD AUSTIN BEVAN VP, CHIEF COMPLIANCE OFFICER

  • Officer
0 2015-06-11 0

GARDON PAUL SR. VP, GENERAL COUNSEL

  • Officer
0 2015-06-11 0

DOWLING ANNE MELISSA

  • Director
36,788 2013-08-19 0

HEIN JASON D SR. VP COMMERCIAL OPERATIONS

  • Officer
0 2013-07-10 0

WERTHEIMER ROGER VP, GENERAL COUNSEL, SECRETARY

  • Officer
11,186 2013-06-01 0

WALKER CRAIG W

  • Director
448,353 2012-10-11 0

BOEHME LISA RENEE VP & GM SALES, MKTG LEAD MGMT

  • Officer
28,279 2012-05-31 0

RIVAS FRANCISCO T. VP, CHIEF COMPLIANCE OFFICER

  • Officer
0 2012-05-31 0

FLETCHER DONALD C JR VP OF QUALITY SYSTEMS

  • Officer
11,250 2012-04-16 0

BLACKBURN DAVID G

  • Director
35,884 2011-06-09 0

RASMUSSEN THOMAS M VP OF CLINICAL AFFAIRS

  • Officer
0 2011-04-15 0

GEISENHEIMER EMILE J DIRECTOR

  • Officer
  • Director
323,527 2011-02-03 0

VAUGHAN JENNIFER VP SALES, VASC. INTERVENTION

  • Officer
3,005 2010-03-01 0

CAIN THOMPSON VP MKTG, VASC. INTERVENTION

  • Officer
0 2009-01-26 0

MCGUIRE JONATHAN WILL COO

  • Officer
0 2008-12-08 0

VOSS MICHAEL J VP & GM, VASCULAR INTERVENTION

  • Officer
0 2008-12-08 0

HANDLEY MICHAEL K VP GLOBAL REG. AFFAIRS & COMP

  • Officer
480 2008-12-08 0

SCHULTE JOHN G CEO

  • Officer
  • Director
77,354 2008-08-28 0

OKLAND STEPHEN D VICE PRESIDENT OF SALES

  • Officer
0 2008-06-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments